Key facts
- This page summarizes ADAMS ROBERT G's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
- 2 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 23 Sep 2025, 16:30.
ADAMS ROBERT G - 19 Sep 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)
- Reporting relationship
- Director
- Issuer ticker
- NHC
- Reported as of
- 19 Sep 2025
- Net transaction value
- +$322,380
- SEC form
- 4
- Accepted by SEC
- 23 Sep 2025, 16:30:40 UTC
- Prior SEC filing
- 09 May 2025
- Next SEC filing
- 29 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Adams
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ADAMS ROBERT G filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 23 Sep 2025.
Change
- Previous filing in this sequence was filed on 09 May 2025.
- Current net transaction value: +$322,380.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001012855
Primary reporting owner
ADAMS ROBERT G
- Relationship
- Director
- Address
- 100 VINE STREET, MURFREESBORO
- Signature
- /s/ Robert Adams
- Signature date
- 22 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NHC
transaction
Shares of Common Stock - Trust I
Options Exercise
- Transaction value
- $322,380
- Shares
- +4,500
- Change %
- +50%
- Price
- $71.64
- Shares after
- 13,579
- Date
- 19 Sep 2025
- Ownership
- Trustee
- Footnotes
- F1
NHC
holding
Shares of Common Stock - Partnership
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 430,341
- Date
- 19 Sep 2025
- Ownership
- General Partner
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NHC
transaction
Derivative
Option to Purchase Common Stock [2021 Grant]
Options Exercise
- Transaction value
- $0
- Shares
- -4,500
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,500
- Exercise price
- $71.64
- Footnotes
- F1
NHC
holding
Derivative
Option to Purchase Common Stock [2022 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 19 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $69.19
NHC
holding
Derivative
Option to Purchase Common Stock [2023 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 19 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $55.75
NHC
holding
Derivative
Option to Purchase Common Stock [2024 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 19 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $96.03
NHC
holding
Derivative
Option to Purchase Common Stock [2025 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 19 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $94.66
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).